587 related articles for article (PubMed ID: 15333579)
21. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein.
Kim HJ; Chae SC; Lee DK; Chromy B; Lee SC; Park YC; Klein WL; Krafft GA; Hong ST
FASEB J; 2003 Jan; 17(1):118-20. PubMed ID: 12424218
[TBL] [Abstract][Full Text] [Related]
22. Chitosan oligosaccharides protect rat primary hippocampal neurons from oligomeric β-amyloid 1-42-induced neurotoxicity.
Dai X; Chang P; Zhu Q; Liu W; Sun Y; Zhu S; Jiang Z
Neurosci Lett; 2013 Oct; 554():64-9. PubMed ID: 23999027
[TBL] [Abstract][Full Text] [Related]
23. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
Kimura M; Akasofu S; Ogura H; Sawada K
Brain Res; 2005 Jun; 1047(1):72-84. PubMed ID: 15893738
[TBL] [Abstract][Full Text] [Related]
24. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
25. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
26. Low-n oligomers as therapeutic targets of Alzheimer's disease.
Ono K; Yamada M
J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
[TBL] [Abstract][Full Text] [Related]
27. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
[TBL] [Abstract][Full Text] [Related]
28. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
Matharu B; El-Agnaf O; Razvi A; Austen BM
Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
[TBL] [Abstract][Full Text] [Related]
29. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
Sakono M; Zako T; Ueda H; Yohda M; Maeda M
FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
[TBL] [Abstract][Full Text] [Related]
30. Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease.
Zetterberg H; Blennow K
Alzheimers Dement; 2013 Jul; 9(4):459-62. PubMed ID: 23159047
[TBL] [Abstract][Full Text] [Related]
31. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization.
Necula M; Breydo L; Milton S; Kayed R; van der Veer WE; Tone P; Glabe CG
Biochemistry; 2007 Jul; 46(30):8850-60. PubMed ID: 17595112
[TBL] [Abstract][Full Text] [Related]
32. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
[TBL] [Abstract][Full Text] [Related]
33. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
34. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
37. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-β: the seeds of darkness.
Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
[TBL] [Abstract][Full Text] [Related]
39. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
40. Oligomerisation differentially affects the acute and chronic actions of amyloid-beta in vitro.
Innocent N; Evans N; Hille C; Wonnacott S
Neuropharmacology; 2010; 59(4-5):343-52. PubMed ID: 20388522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]